Cardinal Health (CAH) — AI Analysis & Mentions

Cardinal Health rose 2.39% to $237.92 and posted its third straight day of gains. The stock outperformed in a positive market session, which suggests investors are warming to the name. When a company can rise while the market is already strong, it often means buyers are seeing something durable in the business.

Cardinal Health impressed with broad business strength and upgraded earnings guidance. The company is well-positioned amid rising specialty drug demand, giving it resilience and tailwinds that fit Buffett's affinity for reliable, essential businesses.

Strong earnings, raised guidance, and a surge in call options indicate growing confidence in Cardinal Health as the company demonstrates operational strength in the healthcare supply chain space.

Short interest in Cardinal Health dropped by over 22% in December after the company handily beat earnings estimates and announced a solid dividend. This reflects renewed investor confidence in the company’s fundamentals, especially attractive for those seeking income and reliability in healthcare distribution.